Try Alerts Free   |   Login
Health Care › Biological Products (No Diagnostic Substances)

Casi Pharmaceuticals (CASI) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 38 quarters since 2012. Compare with CASI stock chart to see long term trends.

CASI stock compared to

CASI Income Statement

Revenue, Net:7162000
Revenue Per Share:0.05
Cost of Goods & Services Sold:2982000
Selling, General & Admin Expense:3360000
Research & Development Expense:2255000
Total Operating Expenses:15140000
Operating Income:-7978000
Income Taxes:null
Net Income:-6946000
Earnings Per Share, Basic:-0.05
Shares Outstanding, Basic Avg:139797487

CASI Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:128000
Change in Accounts Receiveable:-71000
Net Cash from Operations:-7340000
Net Cash from Financing Activities:0
Property, Plant & Equipment Purchases:227000
Net Cash from Investing Activities:-977000
Net Change in Cash & Equivalents:-7760000

CASI Balance Sheet

Cash and Cash Equivalents:60357000
Short-Term Investments:12588000
Accounts Receivable, Net:5767000
Inventories:3475000
Total Current Assets:83505000
Property, Plant & Equipment, Net:3348000
Total Assets:144526000
Accounts Payable:5519000
Current Portion of Long-Term Debt:null
Total Short-Term Liabilities:10021000
Long Term Debt, Non-Current Portion:null
Total Liabilities:27029000

Insider Trading

Change
Value
Transaction
SEC Form 4
He Wei-Wu   Chairman and CEO
480,000 sh at $1
$613,800
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Consonance Capital Management Lp
10,321,956 sh
-218,759 sh
-2%
$15,999
-$9,299
Federated Hermes, Inc.
10,150,000 sh
 
$15,733
Idg-Accel China Growth Fund III Associates L.P.
7,973,536 sh
 
$12,359
Vanguard Group Inc
3,904,627 sh
-319,067 sh
-8%
$6,053
-$4,084
Wellington Shields Capital Management, LLC
2,258,264 sh
26,499 sh
1%
$3,500
-$1,856
Wellington Shields & Co., LLC
1,832,769 sh
 
$2,841
Renaissance Technologies LLC
1,546,306 sh
1,290,606 sh
505%
$2,397
$1,783
Ikarian Capital, LLC
1,268,154 sh
 
$1,966
Blackrock Inc.
1,181,599 sh
-2,825,361 sh
-71%
$1,832
-$7,786
Millennium Management LLC
1,112,208 sh
1,027,417 sh
1212%
$1,724
$1,521
Geode Capital Management, LLC
703,888 sh
-388,789 sh
-36%
$1,091
-$1,531
Ghost Tree Capital, LLC
650,000 sh
 
$1,008
Charles Schwab Investment Management Inc
405,290 sh
-101,436 sh
-20%
$629
-$588
Ergoteles LLC
300,400 sh
300,400 sh
NEW
$466
$466
Dimensional Fund Advisors LP
274,344 sh
11,970 sh
5%
$425
-$205
Northern Trust Corp
243,200 sh
-577,422 sh
-70%
$377
-$1,593
Marshall Wace, Llp
223,709 sh
223,709 sh
NEW
$347
$347
Tibra Equities Europe Ltd
216,300 sh
216,300 sh
NEW
$335
$335
State Street Corp
194,842 sh
-844,900 sh
-81%
$302
-$2,193
JPMorgan Chase & Co
191,523 sh
15,302 sh
9%
$296
-$127

Data imported from Casi Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.